News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Behind-The-Scenes Startup, Scholar Rock, Aims To Hit Disease-Causing Proteins In A "Niche"


1/2/2014 7:15:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

For the better part of a year, Scholar Rock has worked behind the scenes mapping out an approach to hit well-known disease targets in an unusual way. Now, the nascent Cambridge, MA-based startup is ready to discuss what it’s found. Scholar Rock is emerging from stealth mode today to make two announcements: First, it’s licensed intellectual property from Boston Children’s Hospital related to what it calls “niche” activators—the new drug candidates it wants to develop against certain types of growth factors.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy


comments powered by Disqus
Xconomy
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES